Protein tyrosine kinase 2: a novel therapeutic target to overcome acquired EGFR-TKI resistance in non-small cell lung cancerXuexia Tong, Takeshi Isobe|Respiratory Research|2019Cited by 50
Novel drug-resistance mechanisms of pemetrexed-treated non-small cell lung cancerRyosuke Tanino, Takeshi Isobe|Oncotarget|2018Cited by 32